Animal studies have shown that mice with Med23 mutations exhibit hypomyelination and cognitive impairments; however, the functional restoration of MED23 through gene editing has been observed to restore oligodendrocyte maturation and myelin regeneration (Zhang et al., 2024). This evidence concerns the gene MED23 and Cognitive impairment.